ACAD
Price
$19.73
Change
-$0.58 (-2.86%)
Updated
Oct 23 closing price
Capitalization
3.4B
11 days until earnings call
Intraday BUY SELL Signals
IMNM
Price
$17.99
Change
-$0.27 (-1.48%)
Updated
Oct 23 closing price
Capitalization
2.04B
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACAD vs IMNM

ACAD vs IMNM Comparison Chart in %
View a ticker or compare two or three
VS
ACAD vs. IMNM commentary
Oct 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACAD is a Hold and IMNM is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ACAD with price predictions
Oct 23, 2026

ACAD in +6.90% Uptrend, advancing for three consecutive days on October 20, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ACAD advanced for three days, in 189 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ACAD's RSI Oscillator exited the oversold zone, 16 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.

The Moving Average Convergence Divergence (MACD) for ACAD just turned positive on October 15, 2026. Looking at past instances where ACAD's MACD turned positive, the stock continued to rise in 32 of 46 cases over the following month. The odds of a continued upward trend are 70%.

ACAD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Momentum Indicator moved below the 0 level on October 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ACAD as a result. In 67 of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.

The 10-day moving average for ACAD crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 75%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACAD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.

The Aroon Indicator for ACAD entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. ACAD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.602) is normal, around the industry mean (3.043). P/E Ratio (8.730) is within average values for comparable stocks, (-1.361). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (4.168) is also within normal values, averaging (438.009).

The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 91 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACAD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

A.I.Advisor
a Summary for IMNM with price predictions
Oct 23, 2026

IMNM sees its Stochastic Oscillator climbs out of oversold territory

On October 21, 2026, the Stochastic Oscillator for IMNM moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 64 instances where the indicator left the oversold zone. In 60 of the 64 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IMNM's RSI Oscillator exited the oversold zone, 29 of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Moving Average Convergence Divergence (MACD) for IMNM just turned positive on October 22, 2026. Looking at past instances where IMNM's MACD turned positive, the stock continued to rise in 40 of 45 cases over the following month. The odds of a continued upward trend are 89%.

Following a +1.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where IMNM advanced for three days, in 235 of 286 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

IMNM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

IMNM moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for IMNM crossed bearishly below the 50-day moving average on September 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 69%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMNM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for IMNM entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. IMNM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.891) is normal, around the industry mean (3.043). P/E Ratio (-7.111) is within average values for comparable stocks, (-1.361). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (625.000) is also within normal values, averaging (438.009).

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMNM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
ACAD vs IMNM: Fundamental Ratings
ACAD
IMNM
OUTLOOK RATING
1..100
411
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
91100
SMR RATING
1..100
2898
PRICE GROWTH RATING
1..100
7664
P/E GROWTH RATING
1..100
8721
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMNM's Valuation (67) in the null industry is in the same range as ACAD (81) in the Biotechnology industry. This means that IMNM’s stock grew similarly to ACAD’s over the last 12 months.

ACAD's Profit vs Risk Rating (91) in the Biotechnology industry is in the same range as IMNM (100) in the null industry. This means that ACAD’s stock grew similarly to IMNM’s over the last 12 months.

ACAD's SMR Rating (28) in the Biotechnology industry is significantly better than the same rating for IMNM (98) in the null industry. This means that ACAD’s stock grew significantly faster than IMNM’s over the last 12 months.

IMNM's Price Growth Rating (64) in the null industry is in the same range as ACAD (76) in the Biotechnology industry. This means that IMNM’s stock grew similarly to ACAD’s over the last 12 months.

IMNM's P/E Growth Rating (21) in the null industry is significantly better than the same rating for ACAD (87) in the Biotechnology industry. This means that IMNM’s stock grew significantly faster than ACAD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACADIMNM
RSI
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
68%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
68%
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
82%
COMPARISON
Comparison
Oct 24, 2026
Stock price -- (ACAD: $19.73 vs. IMNM: $17.99)
Brand notoriety: ACAD and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACAD: 55% vs. IMNM: 90%
Market capitalization -- ACAD: $3.4B vs. IMNM: $2.04B
ACAD [@Biotechnology] is valued at $3.4B. IMNM’s [@Biotechnology] market capitalization is $2.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $132.8B. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACAD’s FA Score shows that 1 FA rating(s) are green while IMNM’s FA Score has 1 green FA rating(s).

  • ACAD’s FA Score: 1 green, 4 red.
  • IMNM’s FA Score: 1 green, 4 red.
According to our system of comparison, IMNM is a better buy in the long-term than ACAD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACAD’s TA Score shows that 4 TA indicator(s) are bullish while IMNM’s TA Score has 5 bullish TA indicator(s).

  • ACAD’s TA Score: 4 bullish, 5 bearish.
  • IMNM’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than ACAD.

Price Growth

ACAD (@Biotechnology) experienced а +3.19% price change this week, while IMNM (@Biotechnology) price change was +9.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was -16.30%, and the average quarterly price growth was -16.78%.

Reported Earning Dates

ACAD is expected to report earnings on Nov 04, 2026.

IMNM is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ACAD
Daily Signal:
Gain/Loss:
IMNM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ACAD and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACAD has been loosely correlated with CLDX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ACAD jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACAD
1D Price
Change %
ACAD100%
-2.86%
CLDX - ACAD
45%
Loosely correlated
+0.97%
IMNM - ACAD
43%
Loosely correlated
-1.48%
DNLI - ACAD
43%
Loosely correlated
-1.34%
MGTX - ACAD
43%
Loosely correlated
-5.73%
IDYA - ACAD
43%
Loosely correlated
-3.90%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KYTX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-1.48%
KYTX - IMNM
58%
Loosely correlated
-5.93%
SLDB - IMNM
54%
Loosely correlated
-4.36%
EDIT - IMNM
51%
Loosely correlated
-3.61%
LXEO - IMNM
50%
Loosely correlated
-3.11%
FDMT - IMNM
49%
Loosely correlated
-8.86%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PFH14.930.04
+0.27%
Prudential Financial
PTA16.87-0.01
-0.06%
Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund
TPLS24.41-0.05
-0.18%
Thornburg Core Plus Bond ETF (TPLS)
JANU30.28-0.13
-0.43%
AllianzIM U.S. Equity Buffer15 Uncapped Jan ETF
KBWY16.39-0.10
-0.61%
Invesco KBW Premium Yield Equity REIT ETF (KBWY)